John A Scarlett
CIK 1270928 · View on SEC EDGAR ↗
First SEC filing: Oct. 3, 2011 · Latest: Feb. 4, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2025 | GERN | P | 12,500 | $1.76 | $22,000 | 12,500 Direct | — | Acquired | -11.1% (price as of 2026-08-20) |
| June 4, 2024 | GERN | S 10b5-1 | 600,000 | $4.00 | $2,400,000 | 600,000 Direct | -50.00% | Disposed | -60.9% (price as of 2026-08-20) |
| Feb. 10, 2023 | GERN | S 10b5-1 | 446,668 | $3.00 | $1,340,004 | 0 Direct | -100.00% | Disposed | -47.8% (price as of 2026-08-20) |
| Feb. 9, 2023 | GERN | S 10b5-1 | 446,666 | $3.03 | $1,353,398 | 0 Direct | -100.00% | Disposed | -48.3% (price as of 2026-08-20) |
| Feb. 8, 2023 | GERN | S 10b5-1 | 446,666 | $3.08 | $1,375,731 | 0 Direct | -100.00% | Disposed | -49.2% (price as of 2026-08-20) |
| April 1, 2013 | GERN | P | 50,000 | $1.03 | $51,500 | 125,000 Indirect | +66.67% | Acquired | 60.8% (price as of 2026-08-20) |
| Jan. 24, 2012 | GERN | P | 75,000 | $1.72 | $129,000 | 75,000 Direct | — | Acquired | -3.7% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 18, 2025 | GERN | Restricted Stock Units | Common Stock (410,000) | — | — | 410,000 | Acquired |
| Feb. 18, 2025 | GERN | Stock Option (right to buy) | Common Stock (2,457,000) | $2.63 | Feb. 17, 2035 | 2,457,000 | Acquired |
| June 6, 2024 | GERN | Employee Stock Option (right to buy) | Common Stock (1,000,000) | $1.72 | Nov. 6, 2028 | 1,000,000 | Acquired |
| June 4, 2024 | GERN | Stock Option (right to buy) | Common Stock (600,000) | $2.54 | Feb. 11, 2026 | 600,000 | Disposed |
| Feb. 14, 2024 | GERN | Employee Stock Option (Right to Buy) | Common Stock (3,000,000) | $2.10 | Feb. 13, 2034 | 3,000,000 | Acquired |
| Aug. 15, 2023 | GERN | Employee Stock Option (Right to buy) | Common Stock (500,000) | $1.72 | Nov. 6, 2028 | 500,000 | Acquired |
| Feb. 22, 2023 | GERN | Employee Stock Option (Right to buy) | Common Stock (1,750,000) | $2.83 | Feb. 21, 2033 | 1,750,000 | Acquired |
| Feb. 10, 2023 | GERN | Employee Stock Option (right to buy) | Common Stock (446,668) | $1.50 | Feb. 13, 2023 | 446,668 | Disposed |
| Feb. 9, 2023 | GERN | Employee Stock Option (right to buy) | Common Stock (446,666) | $1.50 | Feb. 13, 2023 | 446,666 | Disposed |
| Feb. 8, 2023 | GERN | Employee Stock Option (right to buy) | Common Stock (446,666) | $1.50 | Feb. 13, 2023 | 446,666 | Disposed |
| Feb. 16, 2022 | GERN | Employee Stock Option (Right to buy) | Common Stock (2,100,000) | $1.06 | Feb. 15, 2032 | 2,100,000 | Acquired |
| Feb. 2, 2021 | GERN | Employee Stock Option (Right to buy) | Common Stock (600,000) | $2.06 | Feb. 1, 2031 | 600,000 | Acquired |
| Feb. 12, 2020 | GERN | Employee Stock Option (right to buy) | Common Stock (582,750) | $1.30 | Feb. 11, 2030 | 582,750 | Acquired |
| Jan. 30, 2019 | GERN | Employee Stock Option (right to buy) | Common Stock (1,050,000) | $1.03 | Jan. 29, 2029 | 1,050,000 | Acquired |
| June 13, 2018 | CTMX | Stock Option (Right to Buy) | Common Stock (14,000) | $25.25 | June 12, 2028 | 14,000 | Acquired |
| Jan. 31, 2018 | GERN | Employee Stock Option (right to buy) | Common Stock (1,050,000) | $2.45 | Jan. 31, 2028 | 1,050,000 | Acquired |
| June 20, 2017 | CTMX | Stock Option (right to buy) | Common Stock (14,000) | $13.78 | June 19, 2027 | 14,000 | Acquired |
| Feb. 9, 2017 | GERN | Employee Stock Option (right to buy) | Common Stock (1,050,000) | $2.15 | Feb. 9, 2027 | 1,050,000 | Acquired |
| June 10, 2016 | CTMX | Stock Option (right to buy) | Common Stock (28,000) | $10.17 | June 9, 2026 | 28,000 | Acquired |
| Feb. 11, 2016 | GERN | Employee Stock Option (right to buy) | Common Stock (600,000) | $2.54 | Feb. 11, 2026 | 600,000 | Acquired |
| March 13, 2015 | GERN | Employee Stock Option (right to buy) | Common Stock (600,000) | $4.34 | March 13, 2025 | 600,000 | Acquired |
| Feb. 11, 2014 | GERN | Employee Stock Option (right to buy) | Common Stock (1,340,000) | $5.09 | Feb. 11, 2024 | 1,340,000 | Acquired |
| Feb. 13, 2013 | GERN | Employee Stock Option (right to buy) | Common Stock (1,340,000) | $1.50 | Feb. 13, 2023 | 1,340,000 | Acquired |
| May 17, 2012 | GERN | Employee Stock Option (right to buy) | Common Stock (505,000) | $1.41 | May 17, 2022 | 505,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 3, 2011 | GERN | Stock Option (Right to Buy)→ Common Stock (1,000,000) | 1,000,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
GERN
President & CEO| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $810,600 | — | — | — | $658,600 | — | $64,838 | $6,125,238 |
| 2023 | $787,000 | $17,906 | — | $3,563,000 | $493,694 | — | $62,492 | $4,924,092 |
| 2022 | $761,320 | — | — | — | $671,000 | — | — | $2,997,202 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.